首页> 美国卫生研究院文献>Journal of Medical Genetics >Ovine neuronal ceroid lipofuscinosis: a large animal model syntenic with the human neuronal ceroid lipofuscinosis variant CLN6.
【2h】

Ovine neuronal ceroid lipofuscinosis: a large animal model syntenic with the human neuronal ceroid lipofuscinosis variant CLN6.

机译:绵羊神经元类脂褐藻病:一种大型动物模型与人类神经元类脂褐藻病变体CLN6相似。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited degenerative neurological diseases affecting children. A number of non-allelic variants have been identified within the human population and the genes for some of these have recently been identified. The underlying mechanism for the neuropathology remains an enigma; however, pioneering studies with the naturally occurring ovine model (OCL) have led to the proposal that these diseases represent lesions in specific hydrophobic protein degradation pathways. In this study, we show linkage between OCL and microsatellite markers on OAR 7q13-15. Using interspecies chromosome painting we establish that OAR 7q13-15 is syntenic with human chromosome 15q21-23, the region which was recently defined as the location of a newly identified late infantile variant (CLN6). We propose that our ovine model represents a mutation in the gene orthologous to that mutated in the human late infantile variant CLN6. The ovine linkage flock, consisting of 56 families, represents a powerful resource for positional cloning of this NCL gene. The availability of such a large animal model will have important implications for experimentation in downstream corrective therapies.
机译:神经元类固醇脂褐藻糖(NCL)是影响儿童的一组遗传性退行性神经疾病。在人群中已经鉴定出许多非等位基因变体,并且最近已经鉴定了其中一些的基因。神经病理学的潜在机制仍然是一个谜。但是,对自然存在的绵羊模型(OCL)的开创性研究已经提出了以下建议:这些疾病代表特定疏水蛋白降解途径中的病变。在这项研究中,我们显示了OCL和OAR 7q13-15上的微卫星标记之间的联系。使用种间染色体绘画,我们确定OAR 7q13-15与人类染色体15q21-23具有同义性,该区域最近被定义为新近鉴定的晚期婴儿变异(CLN6)的位置。我们建议,我们的绵羊模型代表与人类晚期婴儿变异CLN6突变的基因同源的基因突变。绵羊连锁群由56个科组成,代表了该NCL基因位置克隆的强大资源。如此大型的动物模型的可用性将对下游纠正疗法的实验产生重要影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号